We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$814M
1-Year Est. Return
40.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.76%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$424M
AUM Growth
+$18.8M
(+4.6%)
Cap. Flow
-$6.82M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
311
New
46
Increased
58
Reduced
107
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.03M |
| 2 |
McDonald's
MCD
|
+$757K |
| 3 |
Colgate-Palmolive
CL
|
+$417K |
| 4 |
Corning
GLW
|
+$349K |
| 5 |
W.P. Carey
WPC
|
+$342K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$990K |
| 2 |
TIF
Tiffany & Co.
TIF
|
+$591K |
| 3 |
Adobe
ADBE
|
+$473K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$431K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$429K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.53% |
| 2 | Industrials | 16.81% |
| 3 | Healthcare | 10.71% |
| 4 | Consumer Discretionary | 7.02% |
| 5 | Financials | 6.91% |
Similar funds
VFG
KCP
AR
CICI
TFM
UAG
PS
BC
Stanley-Laman Group's Q4 2019 Portfolio in Review
As of Q4 2019, Stanley-Laman Group held 311 positions worth $424M, up 4.6% from $405M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Stanley-Laman Group's Q4 2019 filing shows 46 new, 58 increased, 107 reduced and 45 closed positions. Its largest new stake was McDonald's: 3,817 shares worth $754K. The largest sale was Celgene Corp, an estimated $990K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.
- Stanley-Laman Group's largest Q4 2019 buy was McDonald's: 3,817 shares worth $754K.
- Stanley-Laman Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.03M increase.
- Stanley-Laman Group's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $591K.
- Stanley-Laman Group fully exited Celgene Corp in Q4 2019, selling an estimated $990K.
- Stanley-Laman Group's ten largest holdings make up 16% of its $424M portfolio in Q4 2019.
- Stanley-Laman Group opened 46 new positions and closed 45 in Q4 2019.
- Stanley-Laman Group's portfolio value rose 4.6% quarter-over-quarter to $424M.
Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.